US Patent 10030044 Nucleotides for the treatment of liver cancer
Patent 10030044 was granted and assigned to Idenix Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 25, 2014
Date of Patent
July 24, 2018
Patent Applicant
Patent Application Number
15039176
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10030044 Nucleotides for the treatment of liver cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
